The physical state of lipid nanoparticles influences their effect on in vitro cell viability.

[1]  Heike Bunjes,et al.  Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles. , 2010, Journal of colloid and interface science.

[2]  Heike Bunjes,et al.  Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  S. Rossi,et al.  Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. , 2008, International journal of pharmaceutics.

[4]  M. Milek,et al.  Surface active stabilizer tyloxapol in colloidal dispersions exerts cytostatic effects and apoptotic dismissal of cells. , 2008, Toxicology and applied pharmacology.

[5]  P. Constantinides,et al.  Advances in lipid nanodispersions for parenteral drug delivery and targeting. , 2008, Advanced drug delivery reviews.

[6]  M. Carignano,et al.  Effects of block copolymer's architecture on its association with lipid membranes: experiments and simulations. , 2007, The Journal of chemical physics.

[7]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[8]  W. Weyenberg,et al.  Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. , 2007, International journal of pharmaceutics.

[9]  L. Bachmann,et al.  Effect of different lipid emulsions on the immunological function in humans: a systematic review with meta-analysis. , 2007, Clinical nutrition.

[10]  Walter Richter,et al.  Visualizing the structure of triglyceride nanoparticles in different crystal modifications. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[11]  P. Couvreur,et al.  Nanotechnology: Intelligent Design to Treat Complex Disease , 2006, Pharmaceutical Research.

[12]  R. Müller,et al.  Solid lipid nanoparticles (SLN)--effects of lipid composition on in vitro degradation and in vivo toxicity. , 2006, Die Pharmazie.

[13]  K. Barbee,et al.  Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  M. Cruz,et al.  Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  H. Bunjes,et al.  Manufacture, Characterization, and Applications of Solid Lipid Nanoparticles as Drug Delivery Systems , 2005 .

[16]  H. Benson,et al.  Comparison of Diafiltration and Tangential Flow Filtration for Purification of Nanoparticle Suspensions , 2005, Pharmaceutical Research.

[17]  H. Bunjes,et al.  Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers. , 2005, Colloids and surfaces. B, Biointerfaces.

[18]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  H. Bunjes.  Characterization of Solid Lipid Nano-and Microparticles , 2004 .

[20]  H. Bunjes,et al.  Supercooled Smectic Nanoparticles: A Potential Novel Carrier System for Poorly Water Soluble Drugs , 2004, Pharmaceutical Research.

[21]  H. Kristensen,et al.  Preparation and purification of cationic solid lipid nanospheres--effects on particle size, physical stability and cell toxicity. , 2003, International journal of pharmaceutics.

[22]  Thomas Kissel,et al.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. , 2003, Biomaterials.

[23]  Raphael C. Lee,et al.  Direct observation of poloxamer 188 insertion into lipid monolayers. , 2002, Biophysical Journal.

[24]  R. Müller,et al.  Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. , 2002, International journal of pharmaceutics.

[25]  R. Müller,et al.  Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. , 2001, International journal of pharmaceutics.

[26]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[27]  E. Dickinson,et al.  Colloidal dispersions based on solid lipids , 2001 .

[28]  K. Westesen,et al.  Novel lipid-based colloidal dispersions as potential drug administration systems – expectations and reality , 2000 .

[29]  R. Müller,et al.  Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages. , 2000, International journal of pharmaceutics.

[30]  H. Bunjes,et al.  Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential , 1997 .

[31]  K. Westesen,et al.  Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles , 1997 .

[32]  Rainer H. Müller,et al.  Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant , 1997, Pharmaceutical Research.

[33]  R. Müller,et al.  Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles , 1996 .

[34]  Heike Bunjes,et al.  Crystallization tendency and polymorphic transitions in triglyceride nanoparticles , 1996 .

[35]  Feng Liu,et al.  Long-Circulating Emulsions (Oil-in-Water) as Carriers for Lipophilic Drugs , 1995, Pharmaceutical Research.

[36]  H. Bunjes,et al.  Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix , 1995 .

[37]  P. Artursson,et al.  Toxicological and absorption enhancing effects of glycofurol 75 and sodium glycocholate in monolayers of human intestinal epithelial (Caco-2) cells , 1993 .

[38]  E. Papoutsakis,et al.  Polyvinyl alcohol and polyethylene glycol as protectants against fluid-mechanical injury of freely-suspended animal cells (CRL 8018). , 1991, Journal of biotechnology.

[39]  W. Leonhardt,et al.  Elimination and metabolism of a fat emulsion containing medium chain triglycerides (lipofundin MCT 10%). , 1988, JPEN. Journal of parenteral and enteral nutrition.

[40]  Y. Shintani,et al.  Polyethylene glycols for promoting the growth of mammalian cells , 1988, Applied Microbiology and Biotechnology.

[41]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[42]  Joseph H. Finley,et al.  Spectrophotometric determination of polyvinyl alcohol in paper coatings , 1961 .

[43]  Heike Bunjes,et al.  Poly(vinyl alcohol) as emulsifier stabilizes solid triglyceride drug carrier nanoparticles in the alpha-modification. , 2009, Molecular pharmaceutics.

[44]  Alke Petri-Fink,et al.  Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  B. Dupont.  Overview of the lipid formulations of amphotericin B. , 2002, The Journal of antimicrobial chemotherapy.

[46]  E. Dickinson,et al.  Food colloids: fundamentals of formulation. , 2001 .

[47]  J. Swarbrick.  Drugs and the pharmaceutical sciences , 1975 .

[48]  L. S. Wan,et al.  CMC of polysorbates. , 1974, Journal of pharmaceutical sciences.